50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

U.S. Congressional Democrats, Biden reach deal on drug prices

Published 11/02/2021, 10:55 AM
Updated 11/02/2021, 08:00 PM
© Reuters. FILE PHOTO: U.S. Senate Majority Leader Chuck Schumer (D-NY) speaks to reporters following the Senate Democrats weekly policy lunch at the U.S. Capitol in Washington, U.S., October 26, 2021. REUTERS/Elizabeth Frantz/File Photo

WASHINGTON (Reuters) -U.S. President Joe Biden and congressional Democrats reached an agreement on a plan to lower prescription drug prices on Tuesday, the White House and Senate Democratic leader Chuck Schumer said.

The deal, which is much less ambitious than Biden and many Democrats had hoped for, will allow Medicare, the government's health insurance program for the elderly, to negotiate some prescription drug prices.

The agreement will be included in the Biden administration's "Build Back Better" legislation, Schumer told reporters.

"Fixing prescription drug pricing has consistently been a top issue for Americans year after year, including the vast majority of both Democrats and Republicans who want to see a change because they simply cannot afford their medications," Schumer said.

The deal also includes a $2,000 annual cap on out-of-pocket costs for people aged 65 and older, a tax penalty for companies that hike drug prices faster than inflation, and a $35 monthly cap on insulin prices, the White House said in a statement.

It leaves out some of the main provisions Democrats promised voters, such as extending government-negotiated prices to those covered by private insurance, not just Medicare.

The office of Senator Kyrsten Sinema, a Democrat whose support is needed for passage of any bill, said in a statement she supported the agreement following a discussion with Representative Nancy Pelosi, speaker of the House of Representatives and that chamber's top Democrat. Sinema's office called the measure "historic" and "transformative."

Pelosi told reporters the deal was "just about finished. We're very happy about it."

Democrats have been trying to wrap up negotiations on a proposal on social spending and climate change that is the centerpiece of Biden's agenda.

© Reuters. FILE PHOTO: U.S. Senate Majority Leader Chuck Schumer (D-NY) speaks to reporters following the Senate Democrats weekly policy lunch at the U.S. Capitol in Washington, U.S., October 26, 2021. REUTERS/Elizabeth Frantz/File Photo

Biden last week unveiled a $1.75 trillion proposal that would offer free preschool for 3- and 4-year olds, expand home care for the elderly and provide tax credits for companies investing in clean energy sources.

But the package was half the size of Biden's previous $3.5 trillion goal, some priorities were scrapped, such as new paid family leave benefits and some climate control provisions.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.